• Explore /
  • Poster
  • / Five-year follow-up results of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer: JCOG1104 (OPAS-1).

Five-year follow-up results of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer: JCOG1104 (OPAS-1).

Abstract Poster

Authors

null

Souya Nunobe

Cancer Institute Hospital, Department of Gastroenterological Surgery, Tokyo, Japan;

Souya Nunobe , Takaki Yoshikawa , Yasunori Nishida , Takanobu Yamada , Masahide Kaji , Akinori Takagane , Shin Teshima , Hisayuki Matsushita , Ryo Tanaka , Jun Hihara , Hiroshi Katayama , Junki Mizusawa , Haruhiko Fukuda , Narikazu Boku , Masanori Terashima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

000007306

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 381)

DOI

10.1200/JCO.2023.41.4_suppl.381

Abstract #

381

Poster Bd #

B12

Abstract Disclosures

Similar Posters

First Author: Hiroo Ishida

Poster

2021 Gastrointestinal Cancers Symposium

Final results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001).

Final results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001).

First Author: Hitoshi Katai

First Author: Hayato Watanabe

First Author: Kazuya Yamaguchi